- Home
- INSW vs HUMAW Comparison
INSW vs HUMAW Comparison
Compare INSW & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INSW | HUMAW |
|---|---|---|
| Founded | 1999 | 2004 |
| Country | United States | United States |
| Employees | N/A | 220 |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | INSW | HUMAW |
|---|---|---|
| Price | $49.00 | $0.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $48.00 | N/A |
| AVG Volume (30 Days) | ★ 504.1K | 14.2K |
| Earning Date | 11-06-2025 | 03-21-2025 |
| Dividend Yield | ★ 6.10% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.39 | N/A |
| Revenue | ★ $770,036,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.22 | N/A |
| P/E Ratio | $10.95 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $27.20 | $1.18 |
| 52 Week High | $55.18 | $1.34 |
Technical Indicators
Market Signals| Indicator | INSW | HUMAW |
|---|---|---|
| Relative Strength Index (RSI) | 41.10 | 41.99 |
| Support Level | $47.86 | $0.11 |
| Resistance Level | $48.92 | $0.15 |
| Average True Range (ATR) | 1.20 | 0.03 |
| MACD | -0.52 | 0.00 |
| Stochastic Oscillator | 19.52 | 56.71 |
Price Performance
Historical ComparisonAbout INSW International Seaways Inc.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.